NO994083L - Selektiv epoksideringsmetode for fremstilling av farmasöytiske forbindelser - Google Patents
Selektiv epoksideringsmetode for fremstilling av farmasöytiske forbindelserInfo
- Publication number
- NO994083L NO994083L NO994083A NO994083A NO994083L NO 994083 L NO994083 L NO 994083L NO 994083 A NO994083 A NO 994083A NO 994083 A NO994083 A NO 994083A NO 994083 L NO994083 L NO 994083L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- pharmaceutical compounds
- epoxidation method
- selective epoxidation
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/38—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/38—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D303/40—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals by ester radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/38—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D303/46—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals by amide or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Epoxy Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Kryptofycinforbindelser som utviser en B-epoksidel kan bli fremstilt med høy stereoselektivitet ved forskjellige trinn i den syntetiske prosessen. Denne oppfmnelsentilveiebringer også nye intermediater nyttige for å fremstille kryptofycinforbindelser.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3911497P | 1997-02-26 | 1997-02-26 | |
US3911697P | 1997-02-26 | 1997-02-26 | |
PCT/US1998/003667 WO1998038164A1 (en) | 1997-02-26 | 1998-02-25 | Selective epoxidation process for preparing pharmaceutical compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
NO994083D0 NO994083D0 (no) | 1999-08-24 |
NO994083L true NO994083L (no) | 1999-10-25 |
Family
ID=26715826
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO994049A NO994049D0 (no) | 1997-02-26 | 1999-08-23 | Metode for å fremstille farmasöytiske forbindelser |
NO994083A NO994083L (no) | 1997-02-26 | 1999-08-24 | Selektiv epoksideringsmetode for fremstilling av farmasöytiske forbindelser |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO994049A NO994049D0 (no) | 1997-02-26 | 1999-08-23 | Metode for å fremstille farmasöytiske forbindelser |
Country Status (17)
Country | Link |
---|---|
US (1) | US6143909A (no) |
EP (2) | EP0861839A1 (no) |
JP (2) | JP2002513403A (no) |
KR (2) | KR20000075623A (no) |
CN (2) | CN1252788A (no) |
AU (2) | AU738999B2 (no) |
BR (2) | BR9811252A (no) |
CA (2) | CA2281104A1 (no) |
CZ (1) | CZ9902998A3 (no) |
EA (2) | EA199900770A1 (no) |
ID (2) | ID22984A (no) |
IL (2) | IL131205A0 (no) |
NO (2) | NO994049D0 (no) |
NZ (1) | NZ336918A (no) |
PL (2) | PL335347A1 (no) |
TR (2) | TR199902064T2 (no) |
WO (2) | WO1998038164A1 (no) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998008812A1 (en) * | 1996-08-30 | 1998-03-05 | Eli Lilly And Company | Process for preparing pharmaceutical compounds |
EP0929556A4 (en) * | 1996-09-06 | 2001-04-18 | Lilly Co Eli | PROCESS AND NEW INTERMEDIATES |
WO2000023429A2 (en) * | 1998-10-16 | 2000-04-27 | Eli Lilly And Company | Stereoselective process for producing cryptophycins |
WO2000034252A2 (en) * | 1998-12-07 | 2000-06-15 | Eli Lilly And Company | Process for the preparation of cryptophycin derivatives |
WO2000034253A2 (en) * | 1998-12-07 | 2000-06-15 | Eli Lilly And Company | Intermediates and reaction sequence to produce said intermediates useful for the preparation of antineoplastic and antifungal cryptophycin derivatives |
CA2385528C (en) | 1999-10-01 | 2013-12-10 | Immunogen, Inc. | Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
EP1751279A4 (en) | 2004-05-05 | 2008-03-19 | Univ Minnesota | NUCLEIC ACIDS AND POLYPEPTIDES INVOLVED IN THE PREPARATION OF CRYPTOPHYCIN |
CN101962323B (zh) * | 2010-07-16 | 2013-06-05 | 中国人民解放军第二军医大学 | 2-丙烯酰x基-3-取代苯基丙酸类化合物及其用途 |
CN111333560B (zh) * | 2020-04-13 | 2024-01-23 | 合肥工业大学 | 一种制备螺环β-内酰胺的方法 |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4946835A (en) * | 1988-07-15 | 1990-08-07 | Merck & Co., Inc. | Antifungal fermentation product and method |
US4868208A (en) * | 1988-07-15 | 1989-09-19 | Merck & Co., Inc. | Antifungal agent and method |
US4845086A (en) * | 1988-08-09 | 1989-07-04 | Merck & Co., Inc. | Antifungal agent |
US4845085A (en) * | 1988-08-09 | 1989-07-04 | Merck & Co., Inc. | Antifungal agent |
EP0458841B1 (en) * | 1989-02-17 | 1995-06-14 | Chiron Mimotopes Pty. Ltd. | Method for the use and synthesis of peptides |
US5256802A (en) * | 1990-04-03 | 1993-10-26 | Miles Inc. | Process for the production of oxiranes |
WO1994011388A1 (en) * | 1992-11-06 | 1994-05-26 | Chiron Mimotopes Pty. Ltd. | Support for the synthesis of modular polymers |
GB2282384B8 (en) * | 1993-08-18 | 1997-09-04 | Europ Economic Community | Drug delivery agents incorporating mitomycin |
US5952298A (en) * | 1993-12-21 | 1999-09-14 | The University Of Hawaii | Cryptophycins |
ATE203016T1 (de) * | 1993-12-21 | 2001-07-15 | Univ Hawaii | Cryptophycine |
ATE191917T1 (de) * | 1994-10-14 | 2000-05-15 | Stratagene Inc | Porphyrin-markierung von polynukleotiden |
EP0830136B1 (en) * | 1995-03-07 | 2004-10-20 | University Of Hawaii | New cryptophycins from synthesis |
KR100381275B1 (ko) * | 1995-03-31 | 2003-08-19 | 닛뽕 케미파 가부시키가이샤 | 에폭시숙신산유도체 |
US5700826A (en) * | 1995-06-07 | 1997-12-23 | Ontogen Corporation | 1,2,4,5-tetra substituted imidazoles as modulators of multi-drug resistance |
EP0850316A4 (en) * | 1995-08-30 | 2000-08-23 | Univ Hawaii | CRYPTOPHYCINS OBTAINED FROM AN ABERRANT BIOSYNTHESIS |
WO1997023211A1 (en) * | 1995-12-22 | 1997-07-03 | Eli Lilly And Company | Pharmaceutical compounds |
ATE209438T1 (de) * | 1996-02-07 | 2001-12-15 | Buckman Labor Inc | Synergistische antimikrobielle zusammensetzungen, die ein ionene-polymer und ein dodecylaminsalz enthalten und verfahren zu ihrer verwendung |
AU2058197A (en) * | 1996-02-27 | 1997-09-16 | Eli Lilly And Company | Pharmaceutical compounds |
EP0934065B1 (en) * | 1996-08-30 | 2006-06-07 | University Of Hawaii | Novel cryptophycin derivatives as anti-neoplastic agents |
AU4169897A (en) * | 1996-08-30 | 1998-03-19 | Eli Lilly And Company | Pharmaceutical compounds |
CA2263420A1 (en) * | 1996-08-30 | 1998-03-05 | James Edward Ray | Pharmaceutical compounds |
US6025506A (en) * | 1997-02-21 | 2000-02-15 | Dsm N.V. | Process for preparing an optically active phenylglycidyl acid derivative |
TW438787B (en) * | 1997-02-27 | 2001-06-07 | Tanabe Seiyaku Co | Process for preparing optically active trans-3-substituted glycidic acid ester |
-
1998
- 1998-02-25 BR BR9811252-0A patent/BR9811252A/pt not_active IP Right Cessation
- 1998-02-25 PL PL98335347A patent/PL335347A1/xx unknown
- 1998-02-25 EA EA199900770A patent/EA199900770A1/ru unknown
- 1998-02-25 CA CA002281104A patent/CA2281104A1/en not_active Abandoned
- 1998-02-25 US US09/380,005 patent/US6143909A/en not_active Expired - Fee Related
- 1998-02-25 EP EP98301368A patent/EP0861839A1/en not_active Ceased
- 1998-02-25 NZ NZ336918A patent/NZ336918A/en unknown
- 1998-02-25 AU AU66672/98A patent/AU738999B2/en not_active Ceased
- 1998-02-25 CN CN98804250A patent/CN1252788A/zh active Pending
- 1998-02-25 TR TR1999/02064T patent/TR199902064T2/xx unknown
- 1998-02-25 WO PCT/US1998/003667 patent/WO1998038164A1/en not_active Application Discontinuation
- 1998-02-25 CA CA002281108A patent/CA2281108A1/en not_active Abandoned
- 1998-02-25 IL IL13120598A patent/IL131205A0/xx unknown
- 1998-02-25 EA EA199900772A patent/EA002547B1/ru not_active IP Right Cessation
- 1998-02-25 KR KR1019997007686A patent/KR20000075623A/ko not_active Application Discontinuation
- 1998-02-25 EP EP98301367A patent/EP0861838A3/en not_active Withdrawn
- 1998-02-25 WO PCT/US1998/003655 patent/WO1998038158A1/en active Search and Examination
- 1998-02-25 KR KR1019997007737A patent/KR20000075671A/ko not_active Application Discontinuation
- 1998-02-25 PL PL98335478A patent/PL335478A1/xx unknown
- 1998-02-25 JP JP53780398A patent/JP2002513403A/ja active Pending
- 1998-02-25 AU AU66671/98A patent/AU6667198A/en not_active Abandoned
- 1998-02-25 ID IDW990901A patent/ID22984A/id unknown
- 1998-02-25 CZ CZ19992998A patent/CZ9902998A3/cs unknown
- 1998-02-25 IL IL13116298A patent/IL131162A0/xx unknown
- 1998-02-25 TR TR1999/02065T patent/TR199902065T2/xx unknown
- 1998-02-25 ID IDW990900D patent/ID24527A/id unknown
- 1998-02-25 JP JP53779998A patent/JP2002512603A/ja active Pending
- 1998-02-25 CN CN98804251A patent/CN1255121A/zh active Pending
- 1998-02-25 BR BR9807265-0A patent/BR9807265A/pt unknown
-
1999
- 1999-08-23 NO NO994049A patent/NO994049D0/no not_active Application Discontinuation
- 1999-08-24 NO NO994083A patent/NO994083L/no not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU94042903A (ru) | 3,4,4-трехзамещенные пиперидинил-n-алкилкарбоксилаты и промежуточные соединения, способ их получения, фармкомпозиция | |
ATE304358T1 (de) | (s,s)-reboxetin zur behandlung von migränekopfschmerzen | |
DE60222645D1 (de) | Verfahren zur herstellung von oxazolidinonen | |
NO994083L (no) | Selektiv epoksideringsmetode for fremstilling av farmasöytiske forbindelser | |
PT879228E (pt) | Processo para a preparacao de d-treo-(r,r)-metilfenidato e reciclagem de enantiomeros indesejaveis por epimerizacao | |
ES2160410T3 (es) | Preparados de complejos de protrombina inmunotolerantes. | |
BR0210019A (pt) | Processo para a preparação de um composto | |
NO20023150L (no) | Fremgangsmate for fremstilling av citalopram | |
ATE275149T1 (de) | Verfahren zur herstellung von taxanderivaten | |
ATE350372T1 (de) | Verfahren und oxazolidin zwischenprodukt zur herstellung von taxanen | |
DK0811058T3 (da) | Fremgangsmåde til fremstilling af faktor IX ud fra biologiske kilder | |
DE60015563D1 (de) | Verfahren zur herstellung von benzoperhydroisoindolen | |
DE60103560D1 (de) | Prozess zur herstellung von paclitaxel | |
ATE496038T1 (de) | Verfahren zur herstellung von quetiapin | |
ATE244706T1 (de) | Enantiomere von mercaptolactonen und verfahren zu ihrer herstellung | |
HRP20040057B1 (en) | Resolution process for (r)-(-)-2-hydroxy-2-(2-chlorophenyl) acetic acid | |
ATE339423T1 (de) | Verfahren zur herstellung von 4'-o-substituierten 4'-demethyl-1 desoxypodophyllotoxinderivaten und geometrischen isomeren davon ,und antikrebspräparat, das diese enthält | |
FI964446A0 (fi) | Uusia tetrapeptidejä, niiden valmistus ja käyttö | |
ATE298336T1 (de) | Verfahren zur herstellung von thiazolidinedion- derivaten und zwischenprodukte | |
EA200300388A1 (ru) | 1-аминоалкилциклогексаны в качестве трипаноцидных агентов | |
DK0796256T3 (da) | Fremgangsmåde til fremstilling af ranitidin | |
DE59201440D1 (de) | Verfahren zur Herstellung von N,N-disubstituierten m-Aminophenolen. | |
DE50107987D1 (de) | Verfahren zur herstellung von 2,3,5,6-tetrahalogen-xylylidenverbindungen | |
DE60129608D1 (de) | Verfahren zur Herstellung optisch aktiver Epoxide | |
DE50203529D1 (de) | Verfahren zur herstellung von desclarithromycin, sowie zwischenprodukte |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |